nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CA7—colon cancer	0.747	1	CbGaD
Acetazolamide—CA3—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0212	0.156	CbGpPWpGaD
Acetazolamide—CA14—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0137	0.101	CbGpPWpGaD
Acetazolamide—CA5A—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0133	0.0981	CbGpPWpGaD
Acetazolamide—CA6—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0133	0.0981	CbGpPWpGaD
Acetazolamide—CA5B—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0124	0.0916	CbGpPWpGaD
Acetazolamide—CA12—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0115	0.0849	CbGpPWpGaD
Acetazolamide—CA4—Reversible hydration of carbon dioxide—CA7—colon cancer	0.00917	0.0677	CbGpPWpGaD
Acetazolamide—CA2—Reversible hydration of carbon dioxide—CA7—colon cancer	0.0088	0.0649	CbGpPWpGaD
Acetazolamide—CA1—Reversible hydration of carbon dioxide—CA7—colon cancer	0.00843	0.0622	CbGpPWpGaD
Acetazolamide—CA9—Reversible hydration of carbon dioxide—CA7—colon cancer	0.00741	0.0547	CbGpPWpGaD
Acetazolamide—Methazolamide—CA7—colon cancer	0.00675	1	CrCbGaD
Acetazolamide—AQP1—endothelium—colon cancer	0.00491	0.0853	CbGeAlD
Acetazolamide—AQP1—blood vessel—colon cancer	0.00453	0.0787	CbGeAlD
Acetazolamide—AQP1—gall bladder—colon cancer	0.00426	0.074	CbGeAlD
Acetazolamide—CA9—gall bladder—colon cancer	0.00299	0.052	CbGeAlD
Acetazolamide—Hepatic insufficiency—Methotrexate—colon cancer	0.00251	0.0473	CcSEcCtD
Acetazolamide—AQP1—epithelium—colon cancer	0.0022	0.0383	CbGeAlD
Acetazolamide—AQP1—smooth muscle tissue—colon cancer	0.00212	0.0369	CbGeAlD
Acetazolamide—AQP1—renal system—colon cancer	0.00204	0.0355	CbGeAlD
Acetazolamide—Electrolyte imbalance—Irinotecan—colon cancer	0.00187	0.0351	CcSEcCtD
Acetazolamide—AQP1—lymphoid tissue—colon cancer	0.0017	0.0295	CbGeAlD
Acetazolamide—AQP1—digestive system—colon cancer	0.00168	0.0291	CbGeAlD
Acetazolamide—CA7—renal system—colon cancer	0.00163	0.0284	CbGeAlD
Acetazolamide—AQP1—bone marrow—colon cancer	0.00155	0.0269	CbGeAlD
Acetazolamide—CA5A—liver—colon cancer	0.0015	0.0261	CbGeAlD
Acetazolamide—AQP1—vagina—colon cancer	0.00148	0.0257	CbGeAlD
Acetazolamide—CA7—digestive system—colon cancer	0.00134	0.0233	CbGeAlD
Acetazolamide—AQP1—liver—colon cancer	0.00125	0.0217	CbGeAlD
Acetazolamide—CA9—digestive system—colon cancer	0.00118	0.0205	CbGeAlD
Acetazolamide—Reaction gastrointestinal—Methotrexate—colon cancer	0.00116	0.0219	CcSEcCtD
Acetazolamide—CA2—gall bladder—colon cancer	0.00114	0.0197	CbGeAlD
Acetazolamide—CA3—bone marrow—colon cancer	0.00113	0.0197	CbGeAlD
Acetazolamide—CA3—vagina—colon cancer	0.00109	0.0189	CbGeAlD
Acetazolamide—CA12—renal system—colon cancer	0.00106	0.0185	CbGeAlD
Acetazolamide—Numbness—Vincristine—colon cancer	0.000966	0.0182	CcSEcCtD
Acetazolamide—AQP1—lymph node—colon cancer	0.000958	0.0166	CbGeAlD
Acetazolamide—Tingling sensation—Fluorouracil—colon cancer	0.00093	0.0175	CcSEcCtD
Acetazolamide—Sensory loss—Vincristine—colon cancer	0.000925	0.0174	CcSEcCtD
Acetazolamide—CA3—liver—colon cancer	0.000916	0.0159	CbGeAlD
Acetazolamide—Numbness—Fluorouracil—colon cancer	0.000901	0.017	CcSEcCtD
Acetazolamide—CA12—digestive system—colon cancer	0.000871	0.0151	CbGeAlD
Acetazolamide—Sensory loss—Fluorouracil—colon cancer	0.000863	0.0162	CcSEcCtD
Acetazolamide—CA1—renal system—colon cancer	0.000841	0.0146	CbGeAlD
Acetazolamide—CA14—liver—colon cancer	0.000832	0.0145	CbGeAlD
Acetazolamide—Appetite absent—Methotrexate—colon cancer	0.000781	0.0147	CcSEcCtD
Acetazolamide—Urine output increased—Vincristine—colon cancer	0.000724	0.0136	CcSEcCtD
Acetazolamide—CA2—embryo—colon cancer	0.00072	0.0125	CbGeAlD
Acetazolamide—CA3—lymph node—colon cancer	0.000703	0.0122	CbGeAlD
Acetazolamide—CA1—lymphoid tissue—colon cancer	0.000699	0.0121	CbGeAlD
Acetazolamide—CA1—digestive system—colon cancer	0.00069	0.012	CbGeAlD
Acetazolamide—CA5B—vagina—colon cancer	0.00069	0.012	CbGeAlD
Acetazolamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—colon cancer	0.00068	0.00502	CbGpPWpGaD
Acetazolamide—Polyuria—Vincristine—colon cancer	0.000662	0.0125	CcSEcCtD
Acetazolamide—CA4—renal system—colon cancer	0.000658	0.0114	CbGeAlD
Acetazolamide—Tingling sensation—Capecitabine—colon cancer	0.00065	0.0122	CcSEcCtD
Acetazolamide—Hepatic failure—Vincristine—colon cancer	0.000647	0.0122	CcSEcCtD
Acetazolamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—colon cancer	0.000644	0.00475	CbGpPWpGaD
Acetazolamide—Injection site pain—Capecitabine—colon cancer	0.00064	0.012	CcSEcCtD
Acetazolamide—CA1—bone marrow—colon cancer	0.000636	0.0111	CbGeAlD
Acetazolamide—Photosensitivity—Fluorouracil—colon cancer	0.000618	0.0116	CcSEcCtD
Acetazolamide—CA2—epithelium—colon cancer	0.000588	0.0102	CbGeAlD
Acetazolamide—Anaphylactoid reaction—Irinotecan—colon cancer	0.000585	0.011	CcSEcCtD
Acetazolamide—Hyponatraemia—Vincristine—colon cancer	0.000584	0.011	CcSEcCtD
Acetazolamide—Hyponatraemia—Irinotecan—colon cancer	0.000569	0.0107	CcSEcCtD
Acetazolamide—CA2—smooth muscle tissue—colon cancer	0.000566	0.00984	CbGeAlD
Acetazolamide—Ataxia—Vincristine—colon cancer	0.000547	0.0103	CcSEcCtD
Acetazolamide—CA2—renal system—colon cancer	0.000545	0.00947	CbGeAlD
Acetazolamide—CA4—digestive system—colon cancer	0.000539	0.00937	CbGeAlD
Acetazolamide—Irritability—Fluorouracil—colon cancer	0.000518	0.00974	CcSEcCtD
Acetazolamide—Hypokalaemia—Irinotecan—colon cancer	0.000515	0.00969	CcSEcCtD
Acetazolamide—CA1—liver—colon cancer	0.000514	0.00893	CbGeAlD
Acetazolamide—Melaena—Capecitabine—colon cancer	0.00051	0.00959	CcSEcCtD
Acetazolamide—Ataxia—Fluorouracil—colon cancer	0.00051	0.00959	CcSEcCtD
Acetazolamide—CA4—bone marrow—colon cancer	0.000497	0.00864	CbGeAlD
Acetazolamide—AQP1—Metabolism—CA7—colon cancer	0.000496	0.00366	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—HNF4A—colon cancer	0.000486	0.00359	CbGpPWpGaD
Acetazolamide—Urine output increased—Capecitabine—colon cancer	0.000472	0.00888	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Vincristine—colon cancer	0.000459	0.00863	CcSEcCtD
Acetazolamide—CA2—lymphoid tissue—colon cancer	0.000453	0.00787	CbGeAlD
Acetazolamide—CA2—digestive system—colon cancer	0.000447	0.00777	CbGeAlD
Acetazolamide—CA5B—lymph node—colon cancer	0.000446	0.00775	CbGeAlD
Acetazolamide—Hepatic function abnormal—Capecitabine—colon cancer	0.000434	0.00816	CcSEcCtD
Acetazolamide—Photosensitivity—Capecitabine—colon cancer	0.000432	0.00812	CcSEcCtD
Acetazolamide—Polyuria—Capecitabine—colon cancer	0.000432	0.00812	CcSEcCtD
Acetazolamide—CA3—Metabolism—CA7—colon cancer	0.00043	0.00317	CbGpPWpGaD
Acetazolamide—Photosensitivity reaction—Fluorouracil—colon cancer	0.000428	0.00805	CcSEcCtD
Acetazolamide—Hepatic failure—Capecitabine—colon cancer	0.000422	0.00793	CcSEcCtD
Acetazolamide—CA2—bone marrow—colon cancer	0.000412	0.00716	CbGeAlD
Acetazolamide—Hypoaesthesia—Vincristine—colon cancer	0.0004	0.00753	CcSEcCtD
Acetazolamide—Thirst—Capecitabine—colon cancer	0.000398	0.00749	CcSEcCtD
Acetazolamide—CA2—vagina—colon cancer	0.000395	0.00686	CbGeAlD
Acetazolamide—CA1—lymph node—colon cancer	0.000394	0.00685	CbGeAlD
Acetazolamide—Agranulocytosis—Fluorouracil—colon cancer	0.00039	0.00734	CcSEcCtD
Acetazolamide—Hyponatraemia—Capecitabine—colon cancer	0.000381	0.00716	CcSEcCtD
Acetazolamide—Melaena—Methotrexate—colon cancer	0.00038	0.00714	CcSEcCtD
Acetazolamide—Hypoaesthesia—Fluorouracil—colon cancer	0.000373	0.00702	CcSEcCtD
Acetazolamide—Aplastic anaemia—Methotrexate—colon cancer	0.000365	0.00686	CcSEcCtD
Acetazolamide—Flushing—Irinotecan—colon cancer	0.000364	0.00684	CcSEcCtD
Acetazolamide—Irritability—Capecitabine—colon cancer	0.000362	0.0068	CcSEcCtD
Acetazolamide—Ataxia—Capecitabine—colon cancer	0.000356	0.0067	CcSEcCtD
Acetazolamide—CYP3A4—renal system—colon cancer	0.000352	0.00611	CbGeAlD
Acetazolamide—Urine output increased—Methotrexate—colon cancer	0.000351	0.00661	CcSEcCtD
Acetazolamide—Hypokalaemia—Capecitabine—colon cancer	0.000345	0.00649	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—PTGS2—colon cancer	0.000344	0.00254	CbGpPWpGaD
Acetazolamide—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000341	0.00642	CcSEcCtD
Acetazolamide—CA2—liver—colon cancer	0.000333	0.00579	CbGeAlD
Acetazolamide—Agitation—Vincristine—colon cancer	0.000322	0.00605	CcSEcCtD
Acetazolamide—Photosensitivity—Methotrexate—colon cancer	0.000321	0.00604	CcSEcCtD
Acetazolamide—Polyuria—Methotrexate—colon cancer	0.000321	0.00604	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—CASP3—colon cancer	0.000319	0.00235	CbGpPWpGaD
Acetazolamide—Ill-defined disorder—Irinotecan—colon cancer	0.000316	0.00595	CcSEcCtD
Acetazolamide—Hepatic failure—Methotrexate—colon cancer	0.000314	0.0059	CcSEcCtD
Acetazolamide—Leukopenia—Vincristine—colon cancer	0.000313	0.00589	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—CCND1—colon cancer	0.000311	0.00229	CbGpPWpGaD
Acetazolamide—CA4—lymph node—colon cancer	0.000308	0.00535	CbGeAlD
Acetazolamide—Malaise—Irinotecan—colon cancer	0.000308	0.00578	CcSEcCtD
Acetazolamide—Leukopenia—Irinotecan—colon cancer	0.000305	0.00574	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—ABCB1—colon cancer	0.000303	0.00224	CbGpPWpGaD
Acetazolamide—Convulsion—Vincristine—colon cancer	0.000303	0.00571	CcSEcCtD
Acetazolamide—AQP1—Metabolism—ODC1—colon cancer	0.000301	0.00222	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—CHST5—colon cancer	0.000301	0.00222	CbGpPWpGaD
Acetazolamide—CA9—Cellular response to hypoxia—EP300—colon cancer	0.0003	0.00222	CbGpPWpGaD
Acetazolamide—Photosensitivity reaction—Capecitabine—colon cancer	0.000299	0.00562	CcSEcCtD
Acetazolamide—Leukopenia—Fluorouracil—colon cancer	0.000292	0.0055	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Methotrexate—colon cancer	0.000292	0.00548	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00029	0.00545	CcSEcCtD
Acetazolamide—CYP3A4—digestive system—colon cancer	0.000288	0.00501	CbGeAlD
Acetazolamide—Discomfort—Irinotecan—colon cancer	0.000287	0.00539	CcSEcCtD
Acetazolamide—Anaphylactic shock—Vincristine—colon cancer	0.000286	0.00537	CcSEcCtD
Acetazolamide—CA9—Cellular response to hypoxia—VEGFA—colon cancer	0.000284	0.0021	CbGpPWpGaD
Acetazolamide—Convulsion—Fluorouracil—colon cancer	0.000283	0.00532	CcSEcCtD
Acetazolamide—Confusional state—Irinotecan—colon cancer	0.000281	0.00528	CcSEcCtD
Acetazolamide—Thrombocytopenia—Vincristine—colon cancer	0.00028	0.00526	CcSEcCtD
Acetazolamide—Haematuria—Capecitabine—colon cancer	0.000279	0.00524	CcSEcCtD
Acetazolamide—Anaphylactic shock—Irinotecan—colon cancer	0.000278	0.00523	CcSEcCtD
Acetazolamide—CA14—Metabolism—CA7—colon cancer	0.000277	0.00205	CbGpPWpGaD
Acetazolamide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000276	0.00204	CbGpPWpGaD
Acetazolamide—Hepatobiliary disease—Capecitabine—colon cancer	0.000276	0.00519	CcSEcCtD
Acetazolamide—Discomfort—Fluorouracil—colon cancer	0.000275	0.00517	CcSEcCtD
Acetazolamide—Shock—Irinotecan—colon cancer	0.000274	0.00515	CcSEcCtD
Acetazolamide—Agranulocytosis—Capecitabine—colon cancer	0.000273	0.00513	CcSEcCtD
Acetazolamide—Thrombocytopenia—Irinotecan—colon cancer	0.000273	0.00513	CcSEcCtD
Acetazolamide—CA6—Metabolism—CA7—colon cancer	0.00027	0.00199	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CA7—colon cancer	0.00027	0.00199	CbGpPWpGaD
Acetazolamide—Irritability—Methotrexate—colon cancer	0.000269	0.00506	CcSEcCtD
Acetazolamide—Confusional state—Fluorouracil—colon cancer	0.000269	0.00505	CcSEcCtD
Acetazolamide—Anaphylactic shock—Fluorouracil—colon cancer	0.000267	0.00501	CcSEcCtD
Acetazolamide—Ataxia—Methotrexate—colon cancer	0.000265	0.00499	CcSEcCtD
Acetazolamide—Thrombocytopenia—Fluorouracil—colon cancer	0.000261	0.00491	CcSEcCtD
Acetazolamide—Hypoaesthesia—Capecitabine—colon cancer	0.000261	0.00491	CcSEcCtD
Acetazolamide—CA3—Metabolism—ODC1—colon cancer	0.000261	0.00192	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CHST5—colon cancer	0.000261	0.00192	CbGpPWpGaD
Acetazolamide—Paraesthesia—Vincristine—colon cancer	0.000257	0.00483	CcSEcCtD
Acetazolamide—CA2—lymph node—colon cancer	0.000255	0.00444	CbGeAlD
Acetazolamide—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000254	0.00478	CcSEcCtD
Acetazolamide—CA5B—Metabolism—CA7—colon cancer	0.000252	0.00186	CbGpPWpGaD
Acetazolamide—Paraesthesia—Irinotecan—colon cancer	0.00025	0.0047	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—MYC—colon cancer	0.000249	0.00184	CbGpPWpGaD
Acetazolamide—AQP1—Spinal Cord Injury—TGFB1—colon cancer	0.000249	0.00183	CbGpPWpGaD
Acetazolamide—Decreased appetite—Vincristine—colon cancer	0.000248	0.00467	CcSEcCtD
Acetazolamide—Erythema multiforme—Capecitabine—colon cancer	0.000248	0.00466	CcSEcCtD
Acetazolamide—Somnolence—Irinotecan—colon cancer	0.000247	0.00465	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Vincristine—colon cancer	0.000247	0.00464	CcSEcCtD
Acetazolamide—Fatigue—Vincristine—colon cancer	0.000246	0.00463	CcSEcCtD
Acetazolamide—Dyspepsia—Irinotecan—colon cancer	0.000245	0.00461	CcSEcCtD
Acetazolamide—Tinnitus—Capecitabine—colon cancer	0.000244	0.0046	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—EGFR—colon cancer	0.000244	0.0018	CbGpPWpGaD
Acetazolamide—Flushing—Capecitabine—colon cancer	0.000243	0.00458	CcSEcCtD
Acetazolamide—Decreased appetite—Irinotecan—colon cancer	0.000242	0.00455	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Irinotecan—colon cancer	0.00024	0.00452	CcSEcCtD
Acetazolamide—Fatigue—Irinotecan—colon cancer	0.00024	0.00451	CcSEcCtD
Acetazolamide—Paraesthesia—Fluorouracil—colon cancer	0.000239	0.0045	CcSEcCtD
Acetazolamide—Somnolence—Fluorouracil—colon cancer	0.000237	0.00446	CcSEcCtD
Acetazolamide—Dyspepsia—Fluorouracil—colon cancer	0.000235	0.00441	CcSEcCtD
Acetazolamide—CA12—Metabolism—CA7—colon cancer	0.000234	0.00172	CbGpPWpGaD
Acetazolamide—Decreased appetite—Fluorouracil—colon cancer	0.000232	0.00436	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00023	0.00433	CcSEcCtD
Acetazolamide—Feeling abnormal—Irinotecan—colon cancer	0.000229	0.00431	CcSEcCtD
Acetazolamide—Body temperature increased—Vincristine—colon cancer	0.000226	0.00425	CcSEcCtD
Acetazolamide—Dysgeusia—Capecitabine—colon cancer	0.000224	0.0042	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Methotrexate—colon cancer	0.000223	0.00419	CcSEcCtD
Acetazolamide—Body temperature increased—Irinotecan—colon cancer	0.00022	0.00414	CcSEcCtD
Acetazolamide—Feeling abnormal—Fluorouracil—colon cancer	0.00022	0.00413	CcSEcCtD
Acetazolamide—Drowsiness—Methotrexate—colon cancer	0.000217	0.00409	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000216	0.00405	CcSEcCtD
Acetazolamide—CYP3A4—liver—colon cancer	0.000215	0.00373	CbGeAlD
Acetazolamide—Ill-defined disorder—Capecitabine—colon cancer	0.000212	0.00398	CcSEcCtD
Acetazolamide—Urticaria—Fluorouracil—colon cancer	0.000212	0.00398	CcSEcCtD
Acetazolamide—Body temperature increased—Fluorouracil—colon cancer	0.000211	0.00396	CcSEcCtD
Acetazolamide—Haematuria—Methotrexate—colon cancer	0.000207	0.0039	CcSEcCtD
Acetazolamide—Malaise—Capecitabine—colon cancer	0.000206	0.00387	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Methotrexate—colon cancer	0.000206	0.00387	CcSEcCtD
Acetazolamide—Asthenia—Vincristine—colon cancer	0.000205	0.00386	CcSEcCtD
Acetazolamide—AQP1—Spinal Cord Injury—TP53—colon cancer	0.000205	0.00151	CbGpPWpGaD
Acetazolamide—Leukopenia—Capecitabine—colon cancer	0.000204	0.00384	CcSEcCtD
Acetazolamide—Agranulocytosis—Methotrexate—colon cancer	0.000203	0.00382	CcSEcCtD
Acetazolamide—Asthenia—Irinotecan—colon cancer	0.0002	0.00376	CcSEcCtD
Acetazolamide—Diarrhoea—Vincristine—colon cancer	0.000196	0.00368	CcSEcCtD
Acetazolamide—CYP3A4—Metapathway biotransformation—CHST4—colon cancer	0.000193	0.00142	CbGpPWpGaD
Acetazolamide—Discomfort—Capecitabine—colon cancer	0.000192	0.00361	CcSEcCtD
Acetazolamide—Diarrhoea—Irinotecan—colon cancer	0.00019	0.00358	CcSEcCtD
Acetazolamide—Dizziness—Vincristine—colon cancer	0.000189	0.00355	CcSEcCtD
Acetazolamide—Confusional state—Capecitabine—colon cancer	0.000188	0.00353	CcSEcCtD
Acetazolamide—CA4—Metabolism—CA7—colon cancer	0.000186	0.00138	CbGpPWpGaD
Acetazolamide—Erythema multiforme—Methotrexate—colon cancer	0.000185	0.00347	CcSEcCtD
Acetazolamide—Dizziness—Irinotecan—colon cancer	0.000184	0.00346	CcSEcCtD
Acetazolamide—Shock—Capecitabine—colon cancer	0.000183	0.00345	CcSEcCtD
Acetazolamide—Diarrhoea—Fluorouracil—colon cancer	0.000182	0.00343	CcSEcCtD
Acetazolamide—Thrombocytopenia—Capecitabine—colon cancer	0.000182	0.00343	CcSEcCtD
Acetazolamide—Tinnitus—Methotrexate—colon cancer	0.000182	0.00342	CcSEcCtD
Acetazolamide—Vomiting—Vincristine—colon cancer	0.000182	0.00342	CcSEcCtD
Acetazolamide—Headache—Vincristine—colon cancer	0.000179	0.00337	CcSEcCtD
Acetazolamide—CA2—Metabolism—CA7—colon cancer	0.000179	0.00132	CbGpPWpGaD
Acetazolamide—Vomiting—Irinotecan—colon cancer	0.000177	0.00333	CcSEcCtD
Acetazolamide—Dizziness—Fluorouracil—colon cancer	0.000176	0.00332	CcSEcCtD
Acetazolamide—Headache—Irinotecan—colon cancer	0.000174	0.00328	CcSEcCtD
Acetazolamide—CA1—Metabolism—CA7—colon cancer	0.000171	0.00126	CbGpPWpGaD
Acetazolamide—Nausea—Vincristine—colon cancer	0.00017	0.00319	CcSEcCtD
Acetazolamide—AQP1—Transmembrane transport of small molecules—ABCB1—colon cancer	0.00017	0.00125	CbGpPWpGaD
Acetazolamide—Vomiting—Fluorouracil—colon cancer	0.00017	0.00319	CcSEcCtD
Acetazolamide—CA14—Metabolism—CHST5—colon cancer	0.000168	0.00124	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ODC1—colon cancer	0.000168	0.00124	CbGpPWpGaD
Acetazolamide—Paraesthesia—Capecitabine—colon cancer	0.000167	0.00315	CcSEcCtD
Acetazolamide—Headache—Fluorouracil—colon cancer	0.000167	0.00314	CcSEcCtD
Acetazolamide—Dysgeusia—Methotrexate—colon cancer	0.000166	0.00313	CcSEcCtD
Acetazolamide—Nausea—Irinotecan—colon cancer	0.000165	0.00311	CcSEcCtD
Acetazolamide—Dyspepsia—Capecitabine—colon cancer	0.000164	0.00308	CcSEcCtD
Acetazolamide—CA6—Metabolism—ODC1—colon cancer	0.000164	0.00121	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CHST5—colon cancer	0.000164	0.00121	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ODC1—colon cancer	0.000164	0.00121	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CHST5—colon cancer	0.000164	0.00121	CbGpPWpGaD
Acetazolamide—Decreased appetite—Capecitabine—colon cancer	0.000162	0.00305	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Capecitabine—colon cancer	0.000161	0.00302	CcSEcCtD
Acetazolamide—Fatigue—Capecitabine—colon cancer	0.000161	0.00302	CcSEcCtD
Acetazolamide—Nausea—Fluorouracil—colon cancer	0.000158	0.00298	CcSEcCtD
Acetazolamide—Ill-defined disorder—Methotrexate—colon cancer	0.000158	0.00296	CcSEcCtD
Acetazolamide—CA1—C-MYB transcription factor network—PTGS2—colon cancer	0.000156	0.00115	CbGpPWpGaD
Acetazolamide—Feeling abnormal—Capecitabine—colon cancer	0.000154	0.00289	CcSEcCtD
Acetazolamide—Malaise—Methotrexate—colon cancer	0.000153	0.00288	CcSEcCtD
Acetazolamide—CA7—Metabolism—ODC1—colon cancer	0.000153	0.00113	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ODC1—colon cancer	0.000153	0.00113	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CHST5—colon cancer	0.000153	0.00113	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CHST5—colon cancer	0.000153	0.00113	CbGpPWpGaD
Acetazolamide—Leukopenia—Methotrexate—colon cancer	0.000152	0.00286	CcSEcCtD
Acetazolamide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000151	0.00112	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CA7—colon cancer	0.000151	0.00111	CbGpPWpGaD
Acetazolamide—Urticaria—Capecitabine—colon cancer	0.000148	0.00278	CcSEcCtD
Acetazolamide—Body temperature increased—Capecitabine—colon cancer	0.000147	0.00277	CcSEcCtD
Acetazolamide—Convulsion—Methotrexate—colon cancer	0.000147	0.00277	CcSEcCtD
Acetazolamide—Discomfort—Methotrexate—colon cancer	0.000143	0.00269	CcSEcCtD
Acetazolamide—CA12—Metabolism—ODC1—colon cancer	0.000142	0.00104	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CHST5—colon cancer	0.000142	0.00104	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—CCND1—colon cancer	0.000141	0.00104	CbGpPWpGaD
Acetazolamide—Confusional state—Methotrexate—colon cancer	0.00014	0.00263	CcSEcCtD
Acetazolamide—Anaphylactic shock—Methotrexate—colon cancer	0.000139	0.00261	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—EP300—colon cancer	0.000138	0.00102	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—CDKN1A—colon cancer	0.000136	0.001	CbGpPWpGaD
Acetazolamide—Thrombocytopenia—Methotrexate—colon cancer	0.000136	0.00255	CcSEcCtD
Acetazolamide—Asthenia—Capecitabine—colon cancer	0.000134	0.00251	CcSEcCtD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—VEGFA—colon cancer	0.000131	0.000965	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—EP300—colon cancer	0.00013	0.000956	CbGpPWpGaD
Acetazolamide—Diarrhoea—Capecitabine—colon cancer	0.000127	0.0024	CcSEcCtD
Acetazolamide—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000127	0.000939	CbGpPWpGaD
Acetazolamide—Paraesthesia—Methotrexate—colon cancer	0.000125	0.00234	CcSEcCtD
Acetazolamide—Somnolence—Methotrexate—colon cancer	0.000123	0.00232	CcSEcCtD
Acetazolamide—Dizziness—Capecitabine—colon cancer	0.000123	0.00232	CcSEcCtD
Acetazolamide—Dyspepsia—Methotrexate—colon cancer	0.000122	0.0023	CcSEcCtD
Acetazolamide—CA1—C-MYB transcription factor network—NRAS—colon cancer	0.000121	0.000894	CbGpPWpGaD
Acetazolamide—Decreased appetite—Methotrexate—colon cancer	0.000121	0.00227	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Methotrexate—colon cancer	0.00012	0.00225	CcSEcCtD
Acetazolamide—Fatigue—Methotrexate—colon cancer	0.00012	0.00225	CcSEcCtD
Acetazolamide—Vomiting—Capecitabine—colon cancer	0.000118	0.00223	CcSEcCtD
Acetazolamide—Headache—Capecitabine—colon cancer	0.000117	0.00219	CcSEcCtD
Acetazolamide—Feeling abnormal—Methotrexate—colon cancer	0.000114	0.00215	CcSEcCtD
Acetazolamide—CA4—Metabolism—CHST5—colon cancer	0.000113	0.000833	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ODC1—colon cancer	0.000113	0.000833	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—MYC—colon cancer	0.000113	0.000833	CbGpPWpGaD
Acetazolamide—Nausea—Capecitabine—colon cancer	0.000111	0.00208	CcSEcCtD
Acetazolamide—Urticaria—Methotrexate—colon cancer	0.00011	0.00207	CcSEcCtD
Acetazolamide—Body temperature increased—Methotrexate—colon cancer	0.00011	0.00206	CcSEcCtD
Acetazolamide—CA2—Metabolism—ODC1—colon cancer	0.000108	0.000799	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CHST5—colon cancer	0.000108	0.000799	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—KRAS—colon cancer	0.000104	0.000769	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ODC1—colon cancer	0.000104	0.000766	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CHST5—colon cancer	0.000104	0.000766	CbGpPWpGaD
Acetazolamide—Asthenia—Methotrexate—colon cancer	9.95e-05	0.00187	CcSEcCtD
Acetazolamide—Diarrhoea—Methotrexate—colon cancer	9.49e-05	0.00178	CcSEcCtD
Acetazolamide—Dizziness—Methotrexate—colon cancer	9.17e-05	0.00172	CcSEcCtD
Acetazolamide—CA9—Metabolism—ODC1—colon cancer	9.13e-05	0.000673	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CHST5—colon cancer	9.13e-05	0.000673	CbGpPWpGaD
Acetazolamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	9.12e-05	0.000672	CbGpPWpGaD
Acetazolamide—CA1—C-MYB transcription factor network—HRAS—colon cancer	8.87e-05	0.000654	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	8.86e-05	0.000654	CbGpPWpGaD
Acetazolamide—Vomiting—Methotrexate—colon cancer	8.82e-05	0.00166	CcSEcCtD
Acetazolamide—Headache—Methotrexate—colon cancer	8.69e-05	0.00163	CcSEcCtD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	8.69e-05	0.000641	CbGpPWpGaD
Acetazolamide—CA9—HIF-1-alpha transcription factor network—AKT1—colon cancer	8.35e-05	0.000616	CbGpPWpGaD
Acetazolamide—Nausea—Methotrexate—colon cancer	8.24e-05	0.00155	CcSEcCtD
Acetazolamide—AQP1—Metabolism—ABCB1—colon cancer	7.95e-05	0.000586	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—TYMS—colon cancer	7.81e-05	0.000576	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—ABCB1—colon cancer	6.89e-05	0.000508	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—TYMS—colon cancer	6.77e-05	0.000499	CbGpPWpGaD
Acetazolamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	6.04e-05	0.000446	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PPARG—colon cancer	5.53e-05	0.000408	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PPARG—colon cancer	4.79e-05	0.000354	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN1A—colon cancer	4.79e-05	0.000353	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—EP300—colon cancer	4.56e-05	0.000336	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ABCB1—colon cancer	4.44e-05	0.000328	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—TYMS—colon cancer	4.36e-05	0.000322	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTGS2—colon cancer	4.35e-05	0.000321	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ABCB1—colon cancer	4.33e-05	0.000319	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ABCB1—colon cancer	4.33e-05	0.000319	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—colon cancer	4.32e-05	0.000318	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—TYMS—colon cancer	4.25e-05	0.000313	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—TYMS—colon cancer	4.25e-05	0.000313	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ABCB1—colon cancer	4.04e-05	0.000298	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ABCB1—colon cancer	4.04e-05	0.000298	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—TYMS—colon cancer	3.97e-05	0.000293	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—TYMS—colon cancer	3.97e-05	0.000293	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTGS2—colon cancer	3.77e-05	0.000278	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ABCB1—colon cancer	3.74e-05	0.000276	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—TYMS—colon cancer	3.68e-05	0.000271	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—EP300—colon cancer	3.62e-05	0.000267	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—colon cancer	3.26e-05	0.000241	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—EP300—colon cancer	3.14e-05	0.000231	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PPARG—colon cancer	3.09e-05	0.000228	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	3.09e-05	0.000228	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PPARG—colon cancer	3.01e-05	0.000222	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PPARG—colon cancer	3.01e-05	0.000222	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ABCB1—colon cancer	2.99e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—TYMS—colon cancer	2.93e-05	0.000216	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ABCB1—colon cancer	2.86e-05	0.000211	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PPARG—colon cancer	2.81e-05	0.000207	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PPARG—colon cancer	2.81e-05	0.000207	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—TYMS—colon cancer	2.81e-05	0.000207	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ABCB1—colon cancer	2.74e-05	0.000202	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—TYMS—colon cancer	2.69e-05	0.000199	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CA—colon cancer	2.68e-05	0.000197	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PPARG—colon cancer	2.6e-05	0.000192	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CA7—colon cancer	2.54e-05	0.000187	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—colon cancer	2.43e-05	0.000179	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ABCB1—colon cancer	2.41e-05	0.000178	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—TYMS—colon cancer	2.37e-05	0.000175	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—colon cancer	2.37e-05	0.000175	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—colon cancer	2.37e-05	0.000175	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CA—colon cancer	2.32e-05	0.000171	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—colon cancer	2.21e-05	0.000163	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—colon cancer	2.21e-05	0.000163	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—AKT1—colon cancer	2.19e-05	0.000161	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PPARG—colon cancer	2.08e-05	0.000153	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—colon cancer	2.05e-05	0.000151	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—EP300—colon cancer	2.02e-05	0.000149	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PPARG—colon cancer	1.99e-05	0.000147	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—EP300—colon cancer	1.97e-05	0.000145	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—EP300—colon cancer	1.97e-05	0.000145	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PPARG—colon cancer	1.91e-05	0.000141	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—AKT1—colon cancer	1.9e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—EP300—colon cancer	1.84e-05	0.000136	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—EP300—colon cancer	1.84e-05	0.000136	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—EP300—colon cancer	1.7e-05	0.000126	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PPARG—colon cancer	1.68e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—colon cancer	1.63e-05	0.00012	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—colon cancer	1.57e-05	0.000116	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ODC1—colon cancer	1.54e-05	0.000113	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CHST5—colon cancer	1.54e-05	0.000113	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—colon cancer	1.5e-05	0.000111	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CA—colon cancer	1.5e-05	0.00011	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CA—colon cancer	1.46e-05	0.000107	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CA—colon cancer	1.46e-05	0.000107	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CA—colon cancer	1.36e-05	0.0001	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CA—colon cancer	1.36e-05	0.0001	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—EP300—colon cancer	1.36e-05	0.0001	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—colon cancer	1.32e-05	9.74e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—EP300—colon cancer	1.3e-05	9.61e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CA—colon cancer	1.26e-05	9.3e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—EP300—colon cancer	1.25e-05	9.21e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—AKT1—colon cancer	1.22e-05	9.01e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—AKT1—colon cancer	1.19e-05	8.78e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—AKT1—colon cancer	1.19e-05	8.78e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—AKT1—colon cancer	1.11e-05	8.2e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—AKT1—colon cancer	1.11e-05	8.2e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—EP300—colon cancer	1.1e-05	8.1e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—AKT1—colon cancer	1.03e-05	7.59e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CA—colon cancer	1.01e-05	7.41e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CA—colon cancer	9.64e-06	7.11e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CA—colon cancer	9.24e-06	6.81e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—AKT1—colon cancer	8.21e-06	6.06e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CA—colon cancer	8.12e-06	5.99e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—AKT1—colon cancer	7.87e-06	5.81e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—AKT1—colon cancer	7.55e-06	5.57e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—AKT1—colon cancer	6.63e-06	4.89e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCB1—colon cancer	4.06e-06	2.99e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—TYMS—colon cancer	3.99e-06	2.94e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPARG—colon cancer	2.83e-06	2.08e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—colon cancer	2.22e-06	1.64e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—EP300—colon cancer	1.85e-06	1.36e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CA—colon cancer	1.37e-06	1.01e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—AKT1—colon cancer	1.12e-06	8.24e-06	CbGpPWpGaD
